Earlier this month, we talked with Daniel Skovronksy, the Chief Scientific Officer of Eli Lilly, about their colorfully-named COVID-19 treatments. We also discussed the challenges of mass-producing antibodies and how medicine might...

Earlier this month, we talked with Daniel Skovronksy, the Chief Scientific Officer of Eli Lilly, about their colorfully-named COVID-19 treatments. We also discussed the challenges of mass-producing antibodies and how medicine might...

This video discusses the uses of monoclonal antibodies, which are all produced from a single clone of cells and are specific to one binding site on one protein antigen. The video explains how monoclonal antibodies can be used in...

This video provides an overview of how monoclonal antibodies are produced. It starts by explaining the role of lymphocytes and antibodies in the immune system, and how these antibodies bind to specific antigens on pathogens. It then...

This video provides an introduction to producing monoclonal antibodies, explaining what antibodies and lymphocytes are and how they work to destroy specific pathogens. It then goes on to describe monoclonal antibodies. The video also...

Nov.02 -- Tiziana Life Sciences PLC is launching a clinical trial in Brazil involving humans where they will be treated with a nasally administered Foralumab, a monoclonal antibody. Gabriele Cerrone, the chief executive officer, speaks...

Oct.13 -- Adrian Hill M.D., Director, Jenner Institute, University of Oxford talked to Bloomberg News’ Suzi Ring about the possibility of a vaccine against cancer.

President Joe Biden called on Congress to authorize a new round of funding for Covid-19 treatments and vaccines, ratcheting up warnings that U.S. stockpiles are running dry. He spoke at the White House.

An early new survey shows Black COVID patients aren’t being offered antibody therapy at the same rate as white patients.

Dr. Amesh Adalja, Johns Hopkins Center for Health Security senior scholar, discusses antiviral treatments, lockdowns in Europe, and the need to redefine goals for Covid-19. The Johns Hopkins Bloomberg School of Public Health is supported...

Dr. James Crowe, Director of the Vanderbilt Vaccine Center and Chief Scientist of Ahead100 described the benefits of monoclonal antibody treatment to Paul Sweeney and Matt Miller on "Bloomberg Markets: America."